These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9048846)

  • 21. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Sep; 45(RR-12):1-35. PubMed ID: 8801442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics for preventing meningococcal infections.
    Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004785. PubMed ID: 24163051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Present status of polysaccharide vaccines in the prevention of meningococcal disease.
    Gold R; Lepow ML
    Adv Pediatr; 1976; 23():71-93. PubMed ID: 12651
    [No Abstract]   [Full Text] [Related]  

  • 25. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).
    National Center for Immunization and Respiratory Diseases
    MMWR Recomm Rep; 2011 Jan; 60(2):1-64. PubMed ID: 21293327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jan; 60(3):72-6. PubMed ID: 21270745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections.
    Schwartz B
    Rev Infect Dis; 1991; 13 Suppl 2():S170-3. PubMed ID: 2017647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing meningococcal infection in college students.
    Harrison LH
    Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meningococcal polysaccharide vaccines: recommendation of the Public Health Service Advisory Committee on Immunization Practices.
    Ann Intern Med; 1978 Dec; 89(6):949-50. PubMed ID: 102231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance - United States, 2024.
    Berry I; Rubis AB; Howie RL; Sharma S; Marasini D; Marjuki H; Crowe S; McNamara LA
    MMWR Morb Mortal Wkly Rep; 2024 Feb; 73(5):99-103. PubMed ID: 38329923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
    Trotter CL; Ramsay ME
    FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MenACWY-TT vaccine for active immunization against invasive meningococcal disease.
    Papaevangelou V; Spyridis N
    Expert Rev Vaccines; 2012 May; 11(5):523-37. PubMed ID: 22827239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization update: the latest ACIP recommendations.
    Campos-Outcalt D;
    J Fam Pract; 2014 Mar; 63(3):137-40. PubMed ID: 24701599
    [No Abstract]   [Full Text] [Related]  

  • 36. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
    BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningococcal disease--New England, 1993-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(29):629-33. PubMed ID: 10458536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.
    Vickers DM; Anonychuk AM; De Wals P; Demarteau N; Bauch CT
    Vaccine; 2015 Jan; 33(1):268-75. PubMed ID: 24103896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic].
    Krízová P; Vlcková J; Bobák M
    Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):9-14. PubMed ID: 7757351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.
    Pace D
    Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.